Register for real-time alerts, custom portfolio, and market movers

Get Started

SOLY

Soliton (SOLY)

Soliton Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SOLY

<< Previous 1 2 3 4 5 6 7 8 9 Next >>

Date	Time	Source	Headline	Symbol	Company
10/29/2019	8:00AM	PR Newswire (US)	Soliton's Recent Positive Data Increases Potential Fibrotic Indications	NASDAQ:SOLY	Soliton Inc
10/25/2019	8:00AM	PR Newswire (US)	Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive ...	NASDAQ:SOLY	Soliton Inc
10/21/2019	8:00AM	PR Newswire (US)	Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results	NASDAQ:SOLY	Soliton Inc
10/16/2019	6:02AM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SOLY	Soliton Inc
10/15/2019	6:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SOLY	Soliton Inc
10/15/2019	4:15PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SOLY	Soliton Inc
10/15/2019	8:00AM	PR Newswire (US)	Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents	NASDAQ:SOLY	Soliton Inc
10/10/2019	8:30AM	PR Newswire (US)	Soliton Announces $6.25 Million Private Placement	NASDAQ:SOLY	Soliton Inc
10/08/2019	8:00AM	PR Newswire (US)	Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019	NASDAQ:SOLY	Soliton Inc
10/03/2019	8:00AM	PR Newswire (US)	Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice	NASDAQ:SOLY	Soliton Inc
10/01/2019	8:00AM	PR Newswire (US)	Soliton Completes Keloid POC Clinical Trial Treatments	NASDAQ:SOLY	Soliton Inc
09/24/2019	8:00AM	PR Newswire (US)	Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019	NASDAQ:SOLY	Soliton Inc
09/19/2019	4:16PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SOLY	Soliton Inc
09/19/2019	8:45AM	PR Newswire (US)	Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars	NASDAQ:SOLY	Soliton Inc
09/17/2019	8:00AM	PR Newswire (US)	Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial	NASDAQ:SOLY	Soliton Inc
09/10/2019	8:00AM	PR Newswire (US)	Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars	NASDAQ:SOLY	Soliton Inc
09/09/2019	8:32AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SOLY	Soliton Inc
09/09/2019	8:00AM	PR Newswire (US)	Soliton Releases Letter to Shareholders	NASDAQ:SOLY	Soliton Inc
09/04/2019	8:00AM	PR Newswire (US)	Soliton Announces IRB Approval for Keloid Trial	NASDAQ:SOLY	Soliton Inc
08/29/2019	8:00AM	PR Newswire (US)	Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves; Estimated Market Size of $10 Billi...	NASDAQ:SOLY	Soliton Inc
08/26/2019	5:02PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:SOLY	Soliton Inc
08/26/2019	8:00AM	PR Newswire (US)	Soliton Engages argodesign in Preparation of Commercial Launch of its RAP Device	NASDAQ:SOLY	Soliton Inc
08/26/2019	6:00AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SOLY	Soliton Inc
08/20/2019	8:00AM	PR Newswire (US)	Soliton Announces Positive Results Demonstrated from Longer RAP Treatment	NASDAQ:SOLY	Soliton Inc
08/16/2019	8:00AM	PR Newswire (US)	Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference	NASDAQ:SOLY	Soliton Inc
08/14/2019	8:00AM	PR Newswire (US)	Soliton Treats First Patients in Pivotal Cellulite Trial	NASDAQ:SOLY	Soliton Inc
08/12/2019	8:00AM	PR Newswire (US)	Soliton Announces Patient Recruitment Has Begun for Pivotal Cellulite Trial	NASDAQ:SOLY	Soliton Inc
08/09/2019	5:12PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SOLY	Soliton Inc
08/06/2019	5:03PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:SOLY	Soliton Inc
08/06/2019	8:00AM	PR Newswire (US)	Soliton Completes Site Enrollment and Conducts Initial Site Training to Start Pivotal Cellulite Trial	NASDAQ:SOLY	Soliton Inc

Showing the most relevant articles for your search:NASDAQ:SOLY

<< Previous 1 2 3 4 5 6 7 8 9 Next >>

Canopus Biopharma (PK)

Marketing Worldwide (PK)

Gold and GemStone Mining (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Fannie Mae (QB)

Seafarer Exploration (PK)

Brookmount Explorations (PK)

Ubiquitech Software (PK)

Decentral Life (PK)

NioCorp Developments

Seven Arts Entertainment (PK)

Anavex Life Sciences

Delayed Upgrade Clock